The Intellectual Property & Science business of Thomson Reuters, US, has announced that GenoSpace has joined its Life Sciences Partner Ecosystem. The companies will work together to develop an integrated product offering for the analysis and interpretation of human genomic variation.
The GenoSpace platform seeks to establish secure, cloud-based online communities and customised research portals that connect physicians, individuals, and researchers who are interested in using clinical and genomic information; as well as to provide analysis and interpretation tools that support personalised medicine. An essential part of this process will be the detection and annotation of gene variants. Thomson Reuters is in the unique position to collect, annotate and publish a gene variant database and will work with GenoSpace to make this data available to its customers.
Through the Thomson Reuters Life Sciences Partner Ecosystem, the GenoSpace platform will provide access to an unprecedented amount of curated, medically relevant data – from pathway and disease biology to regulatory and financial information. Thomson Reuters and GenoSpace will produce a curated database of genomic variation, with an emphasis on medical and scientific utility.
